A critique of the false-positive report probability

Genetic Epidemiology

Volumn 33, Issue 2, 2009, Pages 145-150

  Lucke, Joseph F ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Bayesian analysis; Conditional error probability; False positive report probability (FPRP); Hypothesis tests; P value

Indexed keywords

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; FALSE POSITIVE RESULT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; HYPOTHESIS; NORMAL DISTRIBUTION; NULL HYPOTHESIS; OBSERVER BIAS; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; EPIDEMIOLOGY; GENETIC PREDISPOSITION; HUMAN; LABORATORY DIAGNOSIS; STATISTICAL MODEL; STATISTICS;

BAYES THEOREM; EPIDEMIOLOGY, MOLECULAR; FALSE POSITIVE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; PROBABILITY;

EID: 63449111695     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20363     Document Type: Article

References (25)

1. Bartle RG, Sherbert DR. 2000. Introduction to Real Analysis, 3rd edition. New York, NY: Wiley.
2. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. 2008. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. J Am Med Assoc 299:2423-2436.
3. Engels EA, Wu X, Go J, Dong Q, Liu J, Spitz MR. 2007. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 67:6520-6527.
4. Garthwaite PH, Kadane JB, O'Hagan A. 2005. Statistical methods for eliciting probability distributions. J Am Stat Assoc 100:680-700.
5. Goodman SN. 1999. Toward evidence-based medicine. 1: the p value fallacy. Ann Intern Med 130:1005-1013.
6. Greenland S. 2006. Bayesian perspectives for epidemiological research: I. Foundations and basic methods. Int J Epidemiol 35:765-775.
7. Hubbard R, Bayarri MJ. 2003. Confusion over measures of evidence (p's) versus errors (α's) in classical statistical testing. Am Statistician 57:171-182.
8. Hung HMJ, O'Neill RT, Bauer P, Kohne K. 1997. The behavior of the p-value when the alternative hypothesis is true. Biometrics 53:1-22.
9. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Borel S, Hall J, Boffetta P. 2005. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 97:567-576.
10. Kadane JB. 1995. Prime time for Bayes. Control Clin Trials 16:313-318.
11. Kraft P. 2006. Efficient two-stage genome-wide association designs based on false positive report probabilities. Pac Symp Biocomput 11:523-534.
12. Lee PM. 2004. Bayesian Statistics:. An Introduction, 3rd edition. London: Hodder Arnold.
13. Matullo G, Berwick M, Vineis P. 2005. Gene-environment interactions: how many false positives? J Natl Cancer Inst 97:550-551.
14. Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC. 2004. SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 13:681-687.
15. Samani N, Erdmann J, Hall A, Hengstenberg C, Mangino M, Mayer B, Dixon R, Meitinger T, Braund P, Wichmann H, Barrett J, König I, Stevens S, Szymczak S, Tregouet D, Iles M, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth A, Baessler A, Ball S, Strom T, Braenne I, Gieger C, Deloukas P, Tobin M, Ziegler A, Thompson J, Schunkert H, the WTCCC, the Cardiogenics Consortium. 2007. Genomewide association analysis of coronary artery disease: supplementary appendix. N Engl J Med 357:443.
16. Sellke T, Bayarri MJ, Berger JO. 2001. Calibration of p values for testing precise null hypotheses. Am Statistician 55:62-71.
17. Spiegelhalter DJ, Freedman LS, Parmar MKB. 1994. Bayesian approaches to randomized trials. J R Stat Soc Ser A (Stat Soc) 157:357-416.
18. Strömberg U, Björk J, Broberg K, Mertens F, Vineis P. 2008. Selection of influential genetic markers among a large number of candidates based on effect estimation rather than hypothesis testing: an approach for genome-wide association studies. Epidemiology 19:302-308.
19. Thomas DC, Clayton DG. 2004. Betting odds and genetic associations. J Natl Cancer Inst 96:421-423.
20. Tobin M, Tomaszewski M, Braund P, Hajat C, Raleigh S, Palmer T, Caulfield M, Burton P, Samani N. 2008. Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension 51:1658-1664.
21. Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
22. Wakefield J. 2007. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 81:208-227.
23. Wakefield J. 2008. Reporting and interpretation in genome-wide association studies. Int J Epidemiol 37:641-653.
24. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678.
25. Ziegler A, König IR, Thompson JR. 2008. Biostatistical aspects of genome-wide association studies. Biometrical J 50:8-28.